Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Scienture Holdings (SCNX) EBITDA (2016 - 2025)

Historic EBITDA for Scienture Holdings (SCNX) over the last 13 years, with Q3 2025 value amounting to -$4.4 million.

  • Scienture Holdings' EBITDA fell 2468.46% to -$4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.3 million, marking a year-over-year decrease of 2528.65%. This contributed to the annual value of -$14.7 million for FY2024, which is 23438.37% down from last year.
  • According to the latest figures from Q3 2025, Scienture Holdings' EBITDA is -$4.4 million, which was down 2468.46% from -$5.2 million recorded in Q2 2025.
  • Scienture Holdings' 5-year EBITDA high stood at -$218763.0 for Q3 2022, and its period low was -$5.5 million during Q1 2024.
  • Its 5-year average for EBITDA is -$2.3 million, with a median of -$1.5 million in 2024.
  • Its EBITDA has fluctuated over the past 5 years, first crashed by 98884.73% in 2021, then soared by 8312.18% in 2022.
  • Scienture Holdings' EBITDA (Quarter) stood at -$782324.0 in 2021, then plummeted by 228.58% to -$2.6 million in 2022, then dropped by 29.38% to -$3.3 million in 2023, then decreased by 26.72% to -$4.2 million in 2024, then dropped by 3.48% to -$4.4 million in 2025.
  • Its last three reported values are -$4.4 million in Q3 2025, -$5.2 million for Q2 2025, and -$3.6 million during Q1 2025.